Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Zymeworks (ZYME) Research & Development (2021 - 2025)

Zymeworks' Research & Development history spans 5 years, with the latest figure at $31.2 million for Q4 2025.

  • On a quarterly basis, Research & Development fell 15.72% to $31.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $137.0 million, a 1.77% increase, with the full-year FY2025 number at $137.0 million, up 1.77% from a year prior.
  • Research & Development hit $31.2 million in Q4 2025 for Zymeworks, down from $35.6 million in the prior quarter.
  • Over the last five years, Research & Development for ZYME hit a ceiling of $62.5 million in Q1 2022 and a floor of $25.5 million in Q4 2023.
  • Historically, Research & Development has averaged $40.5 million across 5 years, with a median of $36.7 million in 2024.
  • Biggest five-year swings in Research & Development: tumbled 51.81% in 2023 and later soared 45.21% in 2024.
  • Tracing ZYME's Research & Development over 5 years: stood at $54.9 million in 2021, then decreased by 3.46% to $53.0 million in 2022, then tumbled by 51.81% to $25.5 million in 2023, then soared by 45.21% to $37.1 million in 2024, then fell by 15.72% to $31.2 million in 2025.
  • Business Quant data shows Research & Development for ZYME at $31.2 million in Q4 2025, $35.6 million in Q3 2025, and $34.4 million in Q2 2025.